216 related articles for article (PubMed ID: 14559909)
1. Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence.
Woo HA; Kang SW; Kim HK; Yang KS; Chae HZ; Rhee SG
J Biol Chem; 2003 Nov; 278(48):47361-4. PubMed ID: 14559909
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine.
Chang TS; Jeong W; Woo HA; Lee SM; Park S; Rhee SG
J Biol Chem; 2004 Dec; 279(49):50994-1001. PubMed ID: 15448164
[TBL] [Abstract][Full Text] [Related]
3. Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.
Noh YH; Baek JY; Jeong W; Rhee SG; Chang TS
J Biol Chem; 2009 Mar; 284(13):8470-7. PubMed ID: 19176523
[TBL] [Abstract][Full Text] [Related]
4. Irreversible oxidation of the active-site cysteine of peroxiredoxin to cysteine sulfonic acid for enhanced molecular chaperone activity.
Lim JC; Choi HI; Park YS; Nam HW; Woo HA; Kwon KS; Kim YS; Rhee SG; Kim K; Chae HZ
J Biol Chem; 2008 Oct; 283(43):28873-80. PubMed ID: 18725414
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid.
Yang KS; Kang SW; Woo HA; Hwang SC; Chae HZ; Kim K; Rhee SG
J Biol Chem; 2002 Oct; 277(41):38029-36. PubMed ID: 12161445
[TBL] [Abstract][Full Text] [Related]
6. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin.
Jönsson TJ; Tsang AW; Lowther WT; Furdui CM
J Biol Chem; 2008 Aug; 283(34):22890-4. PubMed ID: 18593714
[TBL] [Abstract][Full Text] [Related]
7. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins.
Woo HA; Jeong W; Chang TS; Park KJ; Park SJ; Yang JS; Rhee SG
J Biol Chem; 2005 Feb; 280(5):3125-8. PubMed ID: 15590625
[TBL] [Abstract][Full Text] [Related]
8. Novel protective mechanism against irreversible hyperoxidation of peroxiredoxin: Nalpha-terminal acetylation of human peroxiredoxin II.
Seo JH; Lim JC; Lee DY; Kim KS; Piszczek G; Nam HW; Kim YS; Ahn T; Yun CH; Kim K; Chock PB; Chae HZ
J Biol Chem; 2009 May; 284(20):13455-13465. PubMed ID: 19286652
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of peroxiredoxins and their role in the decomposition of peroxynitrite.
Trujillo M; Ferrer-Sueta G; Thomson L; Flohé L; Radi R
Subcell Biochem; 2007; 44():83-113. PubMed ID: 18084891
[TBL] [Abstract][Full Text] [Related]
10. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.
Rhee SG; Jeong W; Chang TS; Woo HA
Kidney Int Suppl; 2007 Aug; (106):S3-8. PubMed ID: 17653208
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine.
Kang SW; Baines IC; Rhee SG
J Biol Chem; 1998 Mar; 273(11):6303-11. PubMed ID: 9497358
[TBL] [Abstract][Full Text] [Related]
12. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation.
Woo HA; Chae HZ; Hwang SC; Yang KS; Kang SW; Kim K; Rhee SG
Science; 2003 Apr; 300(5619):653-6. PubMed ID: 12714748
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes.
Ralat LA; Manevich Y; Fisher AB; Colman RF
Biochemistry; 2006 Jan; 45(2):360-72. PubMed ID: 16401067
[TBL] [Abstract][Full Text] [Related]
14. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.
Rhee SG; Chae HZ; Kim K
Free Radic Biol Med; 2005 Jun; 38(12):1543-52. PubMed ID: 15917183
[TBL] [Abstract][Full Text] [Related]
15. Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity.
Lee SP; Hwang YS; Kim YJ; Kwon KS; Kim HJ; Kim K; Chae HZ
J Biol Chem; 2001 Aug; 276(32):29826-32. PubMed ID: 11390385
[TBL] [Abstract][Full Text] [Related]
16. Multiple functions of 2-Cys peroxiredoxins, I and II, and their regulations via post-translational modifications.
Rhee SG; Woo HA
Free Radic Biol Med; 2020 May; 152():107-115. PubMed ID: 32151745
[TBL] [Abstract][Full Text] [Related]
17. Hyperoxidation of Peroxiredoxins: Gain or Loss of Function?
Veal EA; Underwood ZE; Tomalin LE; Morgan BA; Pillay CS
Antioxid Redox Signal; 2018 Mar; 28(7):574-590. PubMed ID: 28762774
[TBL] [Abstract][Full Text] [Related]
18. Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins.
Woo HA; Bae SH; Park S; Rhee SG
Antioxid Redox Signal; 2009 Apr; 11(4):739-45. PubMed ID: 19113821
[TBL] [Abstract][Full Text] [Related]
19. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress.
Wagner E; Luche S; Penna L; Chevallet M; Van Dorsselaer A; Leize-Wagner E; Rabilloud T
Biochem J; 2002 Sep; 366(Pt 3):777-85. PubMed ID: 12059788
[TBL] [Abstract][Full Text] [Related]
20. Glutaredoxin-dependent peroxiredoxin from poplar: protein-protein interaction and catalytic mechanism.
Rouhier N; Gelhaye E; Jacquot JP
J Biol Chem; 2002 Apr; 277(16):13609-14. PubMed ID: 11832487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
